MicrobiologybioRxivPreprint
Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine candidate
Y.-F. Kang, C. Sun, Z. Zhuang…·M.-S. Zeng
This study designs and tests RBD-conjugated nanoparticle vaccines against SARS-CoV-2, showing enhanced neutralizing activity compared to monomeric RBD.
DOI 10.1101/2020.11.03.366138